Molecular Determinants of Artemisinin Resistance in k13 Gene of Plasmodium falciparum

References (42)

1. 1 Artemisinin Resistance in Plasmodium falciparum Malaria [DOI]
2. 2 Spread of Artemisinin Resistance in Plasmodium falciparum Malaria [DOI]
3. 3 A molecular marker of artemisinin-resistant Plasmodium falciparum malaria [DOI]
4. 4 Evidence of Artemisinin-Resistant Malaria in Western Cambodia [DOI]
5. 5 Mutations in the P. falciparum Digestive Vacuole Transmembrane Protein PfCRT and Evidence for Their Role in Chloroquine Resistance [DOI]
6. 6 A Molecular Marker for Chloroquine-Resistant Falciparum Malaria [DOI]
7. 7 Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study [DOI]
8. 8 Impact of Artemisinin-Based Combination Therapy and Insecticide-Treated Nets on Malaria Burden in Zanzibar [DOI]
9. 9 Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia [DOI]
10. 10 Independent Emergence of Artemisinin Resistance Mutations Among Plasmodium falciparum in Southeast Asia [DOI]
11. 11 Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker [DOI]
12. 12 Estimating the Global Clinical Burden of Plasmodium falciparum Malaria in 2007 [DOI]
13. 13 Absence of Putative Artemisinin Resistance Mutations Among Plasmodium falciparum in Sub-Saharan Africa: A Molecular Epidemiologic Study [DOI]
14. 14 K13-Propeller Polymorphisms in Plasmodium falciparum Parasites From Sub-Saharan Africa [DOI]
15. 15 Dihydroartemisinin–Piperaquine Failure in Cambodia [DOI]
16. 16 Population Genomic Scan for Candidate Signatures of Balancing Selection to Guide Antigen Characterization in Malaria Parasites [DOI]
17. 17 Polymorphisms in K13 and Falcipain-2 Associated with Artemisinin Resistance Are Not Prevalent in Plasmodium falciparum Isolated from Ugandan Children [DOI]
18. 18 Selection and Spread of Artemisinin-Resistant Alleles in Thailand Prior to the Global Artemisinin Resistance Containment Campaign [DOI]
19. 19 Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012–2013 [DOI]
20. 20 Delayed Parasite Clearance after Treatment with Dihydroartemisinin-Piperaquine in Plasmodium falciparum Malaria Patients in Central Vietnam [DOI]
21. 21 Artemisinin resistance—the clock is ticking [DOI]
22. 22 Molecular Assessment of Artemisinin Resistance Markers, Polymorphisms in the K13 Propeller, and a Multidrug-Resistance Gene in the Eastern and Western Border Areas of Myanmar [DOI]
23. 23 Artemisinin resistance in Plasmodium falciparum [DOI]
24. 24 Drug resistance genomics of the antimalarial drug artemisinin [DOI]
25. 25 High‐Level Chloroquine Resistance in Sudanese Isolates ofPlasmodium falciparumIs Associated with Mutations in the Chloroquine Resistance Transporter Genepfcrtand the Multidrug Resistance Genepfmdr1 [DOI]
26. 26 Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America [DOI]
27. 27 Polymorphisms in thePlasmodium falciparum pfcrtandpfmdr‐1Genes and Clinical Response to Chloroquine in Kampala, Uganda [DOI]
28. 28 The origins and spread of antimalarial drug resistance: Lessons for policy makers [DOI]
29. 29 Novel Mutations in K13 Propeller Gene of Artemisinin-ResistantPlasmodium falciparum [DOI]
30. 30 In Vitro Sensitivity of Plasmodium falciparum Clinical Isolates from the China-Myanmar Border Area to Quinine and Association with Polymorphism in the Na + /H + Exchanger [DOI]
31. 31 Polymorphisms in Plasmodium falciparum K13-Propeller in Angola and Mozambique after the Introduction of the ACTs [DOI]
32. 32 Plasmodium falciparum Founder Populations in Western Cambodia Have Reduced Artemisinin Sensitivity In Vitro [DOI]
33. 33 Current Status of Artemisinin-Resistant falciparum Malaria in South Asia: A Randomized Controlled Artesunate Monotherapy Trial in Bangladesh [DOI]
34. 34 Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studies [DOI]
35. 35 Plasmodium falciparumMalaria in Laos: Chloroquine Treatment Outcome and Predictive Value of Molecular Markers [DOI]
36. 36 Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparum [DOI]
37. 37 Role of Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes on In Vitro Chloroquine Resistance in Isolates of Plasmodium falciparum from Thailand [DOI]
38. 38 Prevalence of the K76T Mutation in the PutativePlasmodium falciparumChloroquine Resistance Transporter(pfcrt)Gene and Its Relation to Chloroquine Resistance in Mozambique [DOI]
39. 39 Analysis of the KeypfcrtPoint Mutation and In Vitro and In Vivo Response to Chloroquine in Yaoundé, Cameroon [DOI]
40. 40 Observing in real time the evolution of artemisinin resistance in Plasmodium falciparum [DOI]
41. 41 Analysis of the PfCRT K76T Mutation inPlasmodium falciparumIsolates from the Amazon Region of Brazil [DOI]
42. 42 Plasmodium falciparum pfcrt and pfmdr1 polymorphisms are associated with the pfdhfr N108 pyrimethamine‐resistance mutation in isolates from Ghana [DOI]

Cited by 7

Showing 2 of 7 known citations — external sources report more than can currently be individually listed.

Related research

• ABO Blood Groups and Malaria Prevalence in a Referral Hospital in Nigeria — shares topic coverage
• Prevalence of Malaria among Pregnant Women and Children Under Five Years in Abi Local Government Area, Cross River State, Nigeria — shares topic coverage
• A Study on Relationship of Thrombocytopenia and Likelihood of Severe Malaria in Patients Admitted With Malaria in a Tertiary Care Hospital of Dakshina Kannada — shares topic coverage
• Platelet Alteration in Plasmodium vivax Malaria Patients in Thailand — shares topic coverage
• Patients’ Perception of Health Care Services in Malaria Endemic Area in Mali: Villages with Health Care Services Versus villages Without Health Care Services — shares topic coverage